ArticleCell death & disease2025

Inhibition of TFF3 synergizes with c-MET inhibitors to decrease the CSC-like phenotype and metastatic burden in ER+HER2+ mammary carcinoma.

Chuyu He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.